2025-05-02 11:27:19
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Supriya Lifescience Ltd Q4FY2023 PAT at Rs. 38.22 crores
Posted On : 2023-05-27 00:18:06( TIMEZONE : IST )
Supriya Lifescience Limited has reported Standalone financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 144.235 crores during the period ended March 31, 2023 as compared to Rs. 107.703 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 38.229 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 9.518 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 4.75 for the period ended March 31, 2023 as compared to Rs. 1.18 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹144.235 crs | ₹107.703 crs |  33.92% |
| Net Profit | ₹38.229 crs | ₹9.518 crs | 301.65% |
| EPS | ₹4.75 | ₹1.18 | 302.54% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.144.235 crores during the period ended March 31, 2023 as compared to Rs.185.124 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.38.229 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.46.211 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.4.75 for the period ended March 31, 2023 as compared to Rs.5.74 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹144.235 crs | ₹185.124 crs |  -22.09% |
| Net Profit | ₹38.229 crs | ₹46.211 crs | -17.27% |
| EPS | ₹4.75 | ₹5.74 | -17.25% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.470.427 crores during the Financial Year ended March 31, 2023 as compared to Rs.537.626 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.89.857 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.151.810 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.11.16 for the Financial Year ended March 31, 2023 as compared to Rs.18.86 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹470.427 crs | ₹537.626 crs | -12.50% |
| Net Profit | ₹89.857 crs | ₹151.810 crs | -40.81% |
| EPS | ₹11.16 | ₹18.86 | -40.83% |
Shares of Supriya Lifescience Limited was last trading in BSE at Rs. 257.55 as compared to the previous close of Rs. 258.40. The total number of shares traded during the day was 40477 in over 1078 trades.
The stock hit an intraday high of Rs. 264.85 and intraday low of 255.40. The net turnover during the day was Rs. 10552684.00.
